NRAS mutation renders ovarian cancer cells vulnerable to MEK inhibitor trametinib
Engineered ovarian cancer cell models carrying an activating NRAS mutation showed heightened sensitivity to the MEK inhibitor trametinib, suggesting a ...
Tag: cell line models
POPULAR NEWS
-
Plasma Protein Signatures Predict Rheumatoid Arthritis Years Before Symptoms Appear
-
Ketamine Infusions Rise Sharply Among the Sickest Preterm Infants With Severe Lung Disease
-
NRAS mutation renders ovarian cancer cells vulnerable to MEK inhibitor trametinib
-
Two Muscle Stem Cell Fates Track Hyperplasia and Hypertrophy in Growing Trout